Back to VF Vanguard Fiduciary Trust Co.
KPTI
2 quarters
Position history for VFVanguard Fiduciary Trust Co.'s holdings in Karyopharm Therapeutics Inc.
Yes. Vanguard Fiduciary Trust holds 145,401 shares of KPTI (Karyopharm Therapeutics), worth $1.4M, as of its Q2 2026 13F filing. It increased the position by 30,467 shares (+26.5%) from Q1 2026. Vanguard Fiduciary Trust has held KPTI in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$1.4M
Current Shares
145,401
Total Value Change
+$780,386
Total Shares Change
+30,467
Quarter-by-Quarter History
Other major holders of KPTI: RA Capital Management, L.P., Adage Capital Partners GP, L.L.C., Goldman Sachs Group Inc., BlackRock, Inc.